
Ectopic beats originating from the PVs initiate the majority of paroxysmal AF, 2 and frequency gradients emanating from the posterior LA to the rest of the atria are often seen during sustained fibrillation. In paroxysmal AF, the posterior wall has been demonstrated to have a role in both the initiation and maintenance of AF episodes. Notably, the left atrium (LA) appears to play a dominant role in the establishment and maintenance of AF in most patients with the condition and, in particular, the posterior wall and pulmonary veins (PVs) frequently harbor sources of fibrillation. 1 Catheter ablation improves quality of life in patients with AF and has emerged as either a first-line therapy option or as an alternative therapy in those patients with symptomatic AF refractory to medical therapy. Furthermore, in recent years, the prevalence of AF has risen and is projected to increase threefold by 2050 as the population ages. Paul Mounsey, MD, 160 Dental Circle CB7075, Chapel Hill, NC 27599, USA.Ītrial fibrillation (AF) is the most common sustained arrhythmia in humans and is associated with significant morbidity and mortality. Final version accepted September 12, 2017.Īddress correspondence to: J. Hummel report no conflicts of interest for the published content. Mounsey reports a role as a consultant and receiving speaker’s honoraria from Boston Scientific, Medtronic, and Abbott Laboratories, and receiving speaker’s honoraria from Janssen Pharmaceuticals. Atrial fibrillation, catheter ablation, posterior wall isolation.ĭr. In this review, we will examine the mechanistic role of the posterior left atrium, discuss the technical challenges of ablating in the posterior wall and the evolution of strategies to achieve isolation with catheter approaches, and review the relevant literature to date. Currently, the role of posterior wall isolation during catheter ablation of AF is controversial. The left atrium appears to play a dominant role in the condition of most patients with AF and, in particular, the posterior wall and pulmonary veins frequently harbor sources of fibrillation. Catheter ablation is widely utilized for the management of atrial fibrillation (AF), particularly in patients who are refractory to medical therapy. HUMMEL, MD 2ġ Department of Internal Medicine, Division of Cardiology, University of North Carolina at Chapel Hill, NC, USAĢ Department of Internal Medicine, Division of Cardiac Electrophysiology, University of North Carolina at Chapel Hill, NC, USAĪBSTRACT. Personally visits the Medanta for returning the Device.Posterior Wall Isolation in Atrial Fibrillation Ablation Refund of DepositĪmount shall be made through the same mode of payment as that of purchase in cases where the User The refund of DepositĪmount shall be subject to return of the Device in working and undamaged condition. In cases where the User has opted for availing the Services through rented Device, a refundable depositĪmount of ₹ 5,000 (“ Deposit Amount”) shall be applicable and paid by the User. The extended program availed by the User shall be activated automatically on expiry of existing program of services. For the said purposes, the User can call our helpline number +414 or visit Provided that the Device has not been unboxed.īefore the expiry of service duration, the User can extend the services by availing various program
#Ra ablation for atrial flutter icd 10 pcs full
Service on the day of purchase in which case, full amount of service fees shall be refunded to the User The services once availed cannot be cancelled except in cases where the User requests to cancel the Neither does Medanta endorse or promote the Device in any manner nor will Medanta be liableįor any claims, representations or warranties, whether express or implied as to the safety, reliability,ĭurability and performance of the device. Of services by Medanta is being provided on “as is” and “as available” basis through Alivecor India Private The User hereby agrees and acknowledges that the Device (hardware and software) used in the provision The User agrees and acknowledges that the User has read, understood and accepts the terms and conditions contained in the brochure provided with the Device (“ Device”) with respect to its usage, operations, return / replacement and warranty policy.
